Table of Contents Author Guidelines Submit a Manuscript
Disease Markers
Volume 2014, Article ID 829706, 8 pages
http://dx.doi.org/10.1155/2014/829706
Research Article

Elevated Plasma Stromal-Cell-Derived Factor-1 Protein Levels Correlate with Severity in Patients with Community-Acquired Pneumonia

1Department of Internal Medicine, Zuoying Branch of Kaohsiung Armed Forces General Hospital, Kaohsiung 813, Taiwan
2Department of Emergency Medicine, Chung Shan Medical University Hospital, Taichung 402, Taiwan
3Institute of Medicine, Chung Shan Medical University, No. 110, Section 1, Chien-Kuo N. Road, Taichung 402, Taiwan
4Cancer Research Center, Changhua Christian Hospital, Changhua 500, Taiwan
5Department of Beauty Science, National Taichung University of Science and Technology, Taichung 403, Taiwan
6School of Medicine, Chung Shan Medical University, Taichung 402, Taiwan
7Department of Medical Research, Chung Shan Medical University Hospital, Taichung 402, Taiwan
8Department of Emergency Medicine, School of Medicine, Chung Shan Medical University, Taichung 402, Taiwan

Received 28 April 2014; Revised 2 September 2014; Accepted 18 September 2014; Published 13 October 2014

Academic Editor: Carlo Chiarla

Copyright © 2014 Ping-Kun Tsai et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. N. Lutfiyya, E. Henley, L. F. Chang, and S. W. Reyburn, “Diagnosis and treatment of community-acquired pneumonia,” American Family Physician, vol. 73, no. 3, pp. 442–450, 2006. View at Google Scholar · View at Scopus
  2. G. W. Waterer, J. Rello, and R. G. Wunderink, “Management of community-acquired pneumonia in adults,” The American Journal of Respiratory and Critical Care Medicine, vol. 183, no. 2, pp. 157–164, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. J. A. Ramirez and A. R. Anzueto, “Changing needs of community-acquired pneumonia,” Journal of Antimicrobial Chemotherapy, vol. 66, supplement 3, pp. iii3–iii9, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. Department of Statistics of Ministry of Health and Welfare in Taiwan, Causes of Death in Taiwan, 2012, Ministry of Health and Welfare in Taiwan, Taipei, Taiwan, 2013.
  5. L. Coelho, P. Póvoa, E. Almeida et al., “Usefulness of C-reactive protein in monitoring the severe community-acquired pneumonia clinical course,” Critical Care, vol. 11, article R92, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. U. Thiem, D. Niklaus, B. Sehlhoff et al., “C-reactive protein, severity of pneumonia and mortality in elderly, hospitalised patients with community-acquired pneumonia,” Age and Ageing, vol. 38, no. 6, pp. 693–697, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. J. H. Kim, J. W. Seo, J. H. Mok et al., “Usefulness of plasma procalcitonin to predict severity in elderly patients with community-acquired pneumonia,” Tuberculosis and Respiratory Diseases, vol. 74, no. 5, pp. 207–214, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. S. Ewig, A. Torres, and M. Woodhead, “Assessment of pneumonia severity: a European perspective,” European Respiratory Journal, vol. 27, no. 1, pp. 6–8, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. A. Capelastegui, P. P. España, J. M. Quintana et al., “Validation of a predictive rule for the management of community-acquired pneumonia,” European Respiratory Journal, vol. 27, no. 1, pp. 151–157, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. G. Richards, H. Levy, P.-F. Laterre et al., “CURB-65, PSI, and APACHE II to assess mortality risk in patients with severe sepsis and community acquired pneumonia in PROWESS,” Journal of Intensive Care Medicine, vol. 26, no. 1, pp. 34–40, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Kucia, K. Jankowski, R. Reca et al., “CXCR4-SDF-1 signalling, locomotion, chemotaxis and adhesion,” Journal of Molecular Histology, vol. 35, no. 3, pp. 233–245, 2004. View at Publisher · View at Google Scholar · View at Scopus
  12. J. M. Petty, V. Sueblinvong, C. C. Lenox et al., “Pulmonary stromal-derived factor-1 expression and effect on neutrophil recruitment during acute lung injury,” Journal of Immunology, vol. 178, no. 12, pp. 8148–8157, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. M. J. Delano, K. M. Kelly-Scumpia, T. C. Thayer et al., “Neutrophil mobilization from the bone marrow during polymicrobial sepsis is dependent on CXCL12 signaling,” Journal of Immunology, vol. 187, no. 2, pp. 911–918, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. S. Abi-Younes, A. Sauty, F. Mach, G. K. Sukhova, P. Libby, and A. D. Luster, “The stromal cell-derived factor-1 chemokine is a potent platelet agonist highly expressed in atherosclerotic plaques,” Circulation Research, vol. 86, no. 2, pp. 131–138, 2000. View at Publisher · View at Google Scholar · View at Scopus
  15. C. H. Burgoyne, S. L. Field, A. K. Brown et al., “Abnormal T cell differentiation persists in patients with rheumatoid arthritis in clinical remission and predicts relapse,” Annals of the Rheumatic Diseases, vol. 67, no. 6, pp. 750–757, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. A. M. Leone, S. Rutella, G. Bonanno et al., “Endogenous G-CSF and CD34+ cell mobilization after acute myocardial infarction,” International Journal of Cardiology, vol. 111, no. 2, pp. 202–208, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. L. A. Mandell, R. G. Wunderink, A. Anzueto et al., “Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the management of community-acquired pneumonia in adults,” Clinical Infectious Diseases, vol. 44, no. 2, pp. S27–S72, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. M. J. Fine, T. E. Auble, D. M. Yealy et al., “A prediction rule to identify low-risk patients with community-acquired pneumonia,” The New England Journal of Medicine, vol. 336, no. 4, pp. 243–250, 1997. View at Google Scholar
  19. W. A. Knaus, E. A. Draper, D. P. Wagner, and J. E. Zimmerman, “APACHE II: a severity of disease classification system,” Critical Care Medicine, vol. 13, no. 10, pp. 818–829, 1985. View at Publisher · View at Google Scholar · View at Scopus
  20. W. S. Lim, M. M. Van Der Eerden, R. Laing et al., “Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study,” Thorax, vol. 58, no. 5, pp. 377–382, 2003. View at Publisher · View at Google Scholar · View at Scopus
  21. J. D. Chalmers, A. Singanayagam, and A. T. Hill, “C-reactive protein is an independent predictor of severity in community-acquired pneumonia,” The American Journal of Medicine, vol. 121, no. 3, pp. 219–225, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. R. P. Smith and B. J. Lipworth, “C-reactive protein in simple community-acquired pneumonia,” Chest, vol. 107, no. 4, pp. 1028–1031, 1995. View at Publisher · View at Google Scholar · View at Scopus
  23. A. Torres, P. Ramirez, B. Montull, and R. Menéndez, “Biomarkers and community-acquired pneumonia: tailoring management with biological data,” Seminars in Respiratory and Critical Care Medicine, vol. 33, no. 3, pp. 266–271, 2012. View at Publisher · View at Google Scholar · View at Scopus
  24. C. P. C. de Jager, P. C. Wever, E. F. A. Gemen et al., “The neutrophil-lymphocyte count ratio in patients with community-acquired pneumonia,” PLoS ONE, vol. 7, no. 10, Article ID e46561, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. M. Christ-Crain, N. G. Morgenthaler, D. Stolz et al., “Pro-adrenomedullin to predict severity and outcome in community-acquired pneumonia,” Critical Care, vol. 10, no. 3, article R96, 2006. View at Publisher · View at Google Scholar · View at Scopus
  26. N. Boussekey, O. Leroy, H. Georges, P. Devos, T. D'Escrivan, and B. Guery, “Diagnostic and prognostic values of admission procalcitonin levels in community-acquired pneumonia in an intensive care unit,” Infection, vol. 33, no. 4, pp. 257–263, 2005. View at Publisher · View at Google Scholar · View at Scopus
  27. E. García Vázquez, J. A. Martínez, J. Mensa et al., “C-reactive protein levels in community-acquired pneumonia,” European Respiratory Journal, vol. 21, no. 4, pp. 702–705, 2003. View at Publisher · View at Google Scholar · View at Scopus
  28. S. Black, I. Kushner, and D. Samols, “C-reactive protein,” The Journal of Biological Chemistry, vol. 279, no. 47, pp. 48487–48490, 2004. View at Publisher · View at Google Scholar · View at Scopus
  29. L. Werner, H. Guzner-Gur, and I. Dotan, “Involvement of CXCR4/CXCR7/CXCL12 interactions in inflammatory bowel disease,” Theranostics, vol. 3, no. 1, pp. 40–46, 2013. View at Publisher · View at Google Scholar · View at Scopus
  30. I. F. Charo and R. M. Ransohoff, “Mechanisms of disease: the many roles of chemokines and chemokine receptors in inflammation,” The New England Journal of Medicine, vol. 354, no. 6, pp. 610–621, 2006. View at Publisher · View at Google Scholar · View at Scopus
  31. Y.-S. Kim, L. U. Bigliani, M. Fujisawa et al., “Stromal cell-derived factor 1 (SDF-1, CXCL12) is increased in subacromial bursitis and downregulated by steroid and nonsteroidal anti-inflammatory agents,” Journal of Orthopaedic Research, vol. 24, no. 8, pp. 1756–1764, 2006. View at Publisher · View at Google Scholar · View at Scopus
  32. L. Sánchez-Martín, P. Sánchez-Mateos, and C. Cabañas, “CXCR7 impact on CXCL12 biology and disease,” Trends in Molecular Medicine, vol. 19, no. 1, pp. 12–22, 2013. View at Publisher · View at Google Scholar · View at Scopus
  33. H.-T. Tsai, Y.-T. Tee, Y.-H. Hsieh et al., “Elevated plasma stromal cell-derived factor 1 protein and its gene polymorphism in patients with pelvic inflammatory disease,” Reproductive Sciences, vol. 16, no. 6, pp. 610–617, 2009. View at Publisher · View at Google Scholar · View at Scopus